Product Information

NORETHIND-ETH ESTRAD 1-0.02 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1672 per EA under NDC 68462013281. Its NADAC has been published 541 times since Jul 13, 2016.

FDA first approved this application on Jan 20, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NORETHIND-ETH ESTRAD 1-0.02 MG

Norethindrone Acetate and Ethinyl Estradiol
$0.1672per EA

Strength

.02; 1 mg/1; mg/1

NDC

68462013281

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206969

FDA Approved

1/20/2016

TE Code

AB

On Market Since

1/20/2016

Pharmacological Classes

Estrogen Receptor Agonists
Estrogen
Progesterone Congeners
Progestin

Price Statistics

The NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has been published 541 times since Jul 13, 2016, and over the history we have for it it has declined 78.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1672 per EA
All-time high$0.7935 (Nov 16, 2016)
All-time low$0.1619 (Nov 20, 2024)
52-week high$0.1842
52-week low$0.1652
Median price$0.3174
Average price$0.3448
Largest weekly change+37.1% (May 22, 2019)
Weeks tracked541
Tracking sinceJul 13, 2016

Price History

1W

-5.0%

1M

-7.7%

3M

-9.2%

6M

-1.4%

1Y

+0.4%

3Y

-24.0%

5Y

-49.1%

All

-78.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Norethindrone Acetate and Ethinyl Estradiol market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of NORETHIND-ETH ESTRAD 1-0.02 MG?

The current National Average Drug Acquisition Cost (NADAC) for NORETHIND-ETH ESTRAD 1-0.02 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1672 per EA (NDC 68462013281), effective Nov 18, 2026.

How has the price of NORETHIND-ETH ESTRAD 1-0.02 MG changed over time?

Over the history we have for it, the NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has declined 78.2%. It has been tracked across 541 weekly CMS publications since Jul 13, 2016.

What are the highest and lowest recorded NADAC prices for NORETHIND-ETH ESTRAD 1-0.02 MG?

Since Jul 13, 2016, the NADAC for NORETHIND-ETH ESTRAD 1-0.02 MG has ranged from a low of $0.1619 (Nov 20, 2024) to a high of $0.7935 (Nov 16, 2016), with a median of $0.3174 per EA.

Are there cheaper alternatives to NORETHIND-ETH ESTRAD 1-0.02 MG?

No other NADAC-published product currently shares the active ingredient and strength of NORETHIND-ETH ESTRAD 1-0.02 MG in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures NORETHIND-ETH ESTRAD 1-0.02 MG?

NORETHIND-ETH ESTRAD 1-0.02 MG (NDC 68462013281) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.